INVESTORS.NEOTHETICS.COM HOST
We detected that the main page on investors.neothetics.com took six hundred and thirty-seven milliseconds to come up. I could not discover a SSL certificate, so therefore I consider this site not secure.
Internet Protocol
23.0.160.10
WEBSITE IMAGE
PAGE TITLE
Neothetics - Investor RelationsDESCRIPTION
Neothetics is a specialty pharmaceutical company developing a first-in-class injectable product that has the potential to expand the global body contouring aesthetic market. Phase 3-ready LIPO-202 is for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients. The companys pipeline also includes clinical stage LIPO-102 for the protrusion of the eye associated with thyroid disease caused by expansion of fat and muscle behind the eye. 160; 0.09. Sign up to receive e-mail a.CONTENT
This site investors.neothetics.com had the following on the web page, "Neothetics is a specialty pharmaceutical company developing a first-in-class injectable product that has the potential to expand the global body contouring aesthetic market." We noticed that the website said " Phase 3-ready LIPO-202 is for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients." It also stated " The companys pipeline also includes clinical stage LIPO-102 for the protrusion of the eye associated with thyroid disease caused by expansion of fat and muscle behind the eye. Sign up to receive e-mail a."